: : : 2005-02-22
MEDICAL MALPRACTICE RATES
February 22, 2005 13:34
Speaking before hundreds of doctors and medical workers in a St. Louis suburb, President Bush called attention to a neurosurgeon on stage with him in the small auditorium. The doctor, the president said, waspaying $265,000 a year in premiums for insurance against... (Read Article)
TODD A. SMITH'S RESPONSE TO NEW YORK TIMES' ARTICLE
February 22, 2005 13:35
The Times's article "Behind Those Medical MalpracticeRates" is correct to point out that it has been the declining investment earnings of insurance companies that have caused doctors' malpractice premiums to increase - not malpractice verdicts, which are actually... (Read Article)
BUSH SIGNS BILL TO LIMIT CLASS ACTION SUITS
February 22, 2005 13:36
President Bush signed a bill that he says will curtail multimillion-dollar class actions against companies and help end "the lawsuit culture in our country." The legislation aims to discourage class action suits by having federal judges take them away from... (Read Article)
A VIOXX COMEBACK COULD TILT BALANCE IN MERCK LITIGATION
February 22, 2005 13:37
The possibility that Vioxx may once again be offered to patients raises a provocative question: Did Merck & Co. err by pulling its $2.5 billion painkiller off the market? Critics had raised safety issues about Vioxx for years, but it wasn't until late last... (Read Article)
Its time for the media to inform the public of the reasons why Merck and other drug companies have been trying to hide the damage caused by mercury in childhood vaccines.
February 22, 2005 13:50
Thimerosal has been harming kids. When will the drug companies come clean about this?
Why would government regulatory agencies deliberately deceive the American public by hiding the results of a study conducted in 1999, that proved there was a direct link between autism and the mercury-based preservative, Thirmosal, contained in childhood vaccines?
http://www.independent-media.tv/item.cfm?fmedia_id=10422&fcategory_desc=Under%20Reported
abitril (tiagabine) associated with risk of seizures
February 22, 2005 15:03
FDA MedWatch: Gabitril (tiagabine) associated with risk of seizures in patients without epilepsy treated off labelFDA and Cephalon, Inc. notified healthcare professionals and the public that a Bolded Warning has been added to the labeling for Gabitril (tiagabine)... (Read Article)